DK0752987T3 - Pyrimidinylderivater som interleukininhibitorer - Google Patents

Pyrimidinylderivater som interleukininhibitorer

Info

Publication number: DK0752987T3
Authority: DK; Denmark
Prior art keywords: beta; compounds; aspartic acid; protease activity; pyrimidinyl
Prior art date: 1994-03-31

Application number

DK95915448T

Other languages

Danish (da)

English (en)

Inventor

Roland E Dolle

Catherine P Prouty

Prasad V Chaturvedula

Stanley J Schmidt

Original Assignee

Vertex Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-31

Filing date

1995-03-29

Publication date

2004-03-15

1995-03-29 Application filed by Vertex Pharma filed Critical Vertex Pharma

2004-03-15 Application granted granted Critical

2004-03-15 Publication of DK0752987T3 publication Critical patent/DK0752987T3/da

Links

229940046732 interleukin inhibitors Drugs 0.000 title 1
125000000714 pyrimidinyl group Chemical group 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
108091005804 Peptidases Proteins 0.000 abstract 2
239000004365 Protease Substances 0.000 abstract 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
TVZJDRYAFYBTRU-YFKPBYRVSA-N (2s)-2-(pyrimidin-2-ylamino)butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NC1=NC=CC=N1 TVZJDRYAFYBTRU-YFKPBYRVSA-N 0.000 abstract 1
LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 abstract 1
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 1
102000004190 Enzymes Human genes 0.000 abstract 1
108090000790 Enzymes Proteins 0.000 abstract 1
102000003777 Interleukin-1 beta Human genes 0.000 abstract 1
108090000193 Interleukin-1 beta Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
235000003704 aspartic acid Nutrition 0.000 abstract 1
-1 aspartic acid aldehydes Chemical class 0.000 abstract 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Crystallography & Structural Chemistry (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK95915448T 1994-03-31 1995-03-29 Pyrimidinylderivater som interleukininhibitorer DK0752987T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22171294A	1994-03-31	1994-03-31
PCT/US1995/003909 WO1995026958A1 (fr)	1994-03-31	1995-03-29	Derives du pyrimidinyle inhibiteurs de l'interleukine

Publications (1)

Publication Number	Publication Date
DK0752987T3 true DK0752987T3 (da)	2004-03-15

Family

ID=22829018

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95915448T DK0752987T3 (da)	1994-03-31	1995-03-29	Pyrimidinylderivater som interleukininhibitorer

Country Status (17)

Country	Link
US (3)	US5670494A (fr)
EP (1)	EP0752987B1 (fr)
JP (1)	JP3703836B2 (fr)
CN (2)	CN1118458C (fr)
AT (1)	ATE254111T1 (fr)
AU (1)	AU703451B2 (fr)
CA (1)	CA2186511C (fr)
DE (1)	DE69532113T2 (fr)
DK (1)	DK0752987T3 (fr)
ES (1)	ES2210289T3 (fr)
FI (1)	FI112943B (fr)
HU (1)	HU224731B1 (fr)
MX (1)	MX9604420A (fr)
NO (1)	NO308603B1 (fr)
NZ (1)	NZ283876A (fr)
PT (1)	PT752987E (fr)
WO (1)	WO1995026958A1 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6008217A (en) *	1995-12-20	1999-12-28	Vertex Pharmaceuticals Incorporated	Inhibitors of interleukin-1β converting enzyme
US6204261B1 (en)	1995-12-20	2001-03-20	Vertex Pharmaceuticals Incorporated	Inhibitors of interleukin-1β Converting enzyme inhibitors
US5874424A (en) *	1995-12-20	1999-02-23	Vertex Pharmaceuticals Incorporated	Inhibitors of interleukin-1β converting enzyme
US5714484A (en) *	1993-12-08	1998-02-03	Prototek, Inc.	α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
CA2186511C (fr) *	1994-03-31	2009-02-10	Roland E. Dolle	Derives du pyrimidinyle inhibiteurs de l'interleukine
US6420522B1 (en)	1995-06-05	2002-07-16	Vertex Pharmaceuticals Incorporated	Inhibitors of interleukin-1β converting enzyme
US5756466A (en) *	1994-06-17	1998-05-26	Vertex Pharmaceuticals, Inc.	Inhibitors of interleukin-1β converting enzyme
US5847135A (en) *	1994-06-17	1998-12-08	Vertex Pharmaceuticals, Incorporated	Inhibitors of interleukin-1β converting enzyme
US5716929A (en) *	1994-06-17	1998-02-10	Vertex Pharmaceuticals, Inc.	Inhibitors of interleukin-1β converting enzyme
US6001814A (en) *	1994-11-21	1999-12-14	Cortech Inc.	Serine protease inhibitors
US6011158A (en) *	1994-12-13	2000-01-04	Corvas International, Inc.	Aromatic heterocyclic derivatives as enzyme inhibitors
WO1996018644A1 (fr) *	1994-12-13	1996-06-20	Corvas International, Inc.	Derives aromatiques heterocycliques utilisables comme inhibiteurs d'enzymes
EP0820464A2 (fr) *	1995-03-31	1998-01-28	Takeda Chemical Industries, Ltd.	Inhibiteur de la protease de cysteine
US5948785A (en) *	1995-04-27	1999-09-07	The Green Cross Corporation	Heterocyclic amide compounds and pharmaceutical use of the same
US5843904A (en) *	1995-12-20	1998-12-01	Vertex Pharmaceuticals, Inc.	Inhibitors of interleukin-1βconverting enzyme
US6136834A (en) *	1995-12-27	2000-10-24	Ono Pharmaceutical Co., Ltd.	Tetrazole compounds and pharmaceutical agents containing such derivative
US5919790A (en) *	1996-10-11	1999-07-06	Warner-Lambert Company	Hydroxamate inhibitors of interleukin-1β converting enzyme
US6316415B1 (en)	1996-10-11	2001-11-13	Basf Aktiengesellschaft	Sulfonamide interleukin-1β converting enzyme inhibitors
WO1998016504A2 (fr) *	1996-10-11	1998-04-23	Warner-Lambert Company	INHIBITEURS DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE 1β A BASE D'ACIDE ASPARTIQUE A SUBSTITUTION SULFONAMIDE
DK1049703T3 (da) *	1998-01-20	2003-06-02	Abbott Gmbh & Co Kg	N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2--(4-fluorphenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-L-asparaginsyrealdehyd som en in vivo inhibitor af interleukin-1beta konverterende enzym
WO1999046248A1 (fr)	1998-03-09	1999-09-16	Vertex Pharmaceuticals Incorporated	DERIVES DE LA 1,2-DIAZEPANE INHIBITEURS DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE-1$g(b)
CA2324226C (fr)	1998-03-19	2012-06-05	Vertex Pharmaceuticals Incorporated	Inhibiteurs de caspases
KR20010078725A (ko) *	1998-06-03	2001-08-21	존 더블류. 갈루치 2세	세린 프로테아제 저해제로서의 펩토이드 및 비펩토이드를함유하는 알파-케토 옥사디아졸
WO2000005250A1 (fr)	1998-07-23	2000-02-03	Yeda Research And Development Co., Ltd	Traitement de maladies auto-immunes a l'aide du copolymere 1 et des copolymeres et peptides apparentes
ES2527760T3 (es) *	1998-07-23	2015-01-29	Yeda Research And Development Co., Ltd.	Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
US6800287B2 (en) *	1998-09-25	2004-10-05	Yeda Research And Development Co., Ltd.	Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
US6972296B2 (en)	1999-05-07	2005-12-06	Encysive Pharmaceuticals Inc.	Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
ZA200206457B (en) *	2000-02-18	2003-08-13	Yeda Res & Dev	Oral, nasal and pulmonary dosage formulations of copolymer 1.
EP2241328A1 (fr)	2000-05-12	2010-10-20	Immunex Corporation	Inhibiteurs d'interleukine 1 dans le traitement de maladies
PE20011350A1 (es)	2000-05-19	2002-01-15	Vertex Pharma	PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
US20020077278A1 (en)	2000-06-05	2002-06-20	Yong V. Wee	Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (fr) *	2000-06-20	2002-10-03	Mayo Foundation For Medical Education And Research	Traitement de maladies du systeme nerveux central au moyen d'anticorps diriges contre l'acetate de glatiramere
EP1301490A2 (fr) *	2000-07-18	2003-04-16	Neurogen Corporation	2-aryl-4-pyrimidinones 5-substituees
CA2469393C (fr) *	2001-12-04	2010-05-25	Teva Pharmaceutical Industries, Ltd.	Procedes pour mesurer la puissance de l'acetate de glatiramer
US7410956B2 (en) *	2002-02-11	2008-08-12	Vertex Pharmaceuticals Incorporated	Caspase inhibitor prodrugs
US7001899B2 (en) *	2002-06-10	2006-02-21	The Procter & Gamble Company	Interleukin converting enzyme inhibitors
EP1553090A4 (fr) *	2002-06-14	2006-07-05	Ajinomoto Kk	Procede de preparation de composes de pyrimidine
PE20050159A1 (es)	2003-05-27	2005-04-19	Vertex Pharma	Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa
AU2005249503B2 (en)	2003-11-10	2011-08-25	Vertex Pharmaceuticals Incorporated	ICE inhibitors for the treatment of autoinflammatory diseases
CA2566362C (fr) *	2004-05-15	2013-09-10	Vertex Pharmaceuticals Incorporated	Traitement de crises epileptiques au moyen d'inhibiteurs ice
JP5055129B2 (ja)	2004-11-24	2012-10-24	バーテックスファーマシューティカルズインコーポレイテッド	３−［２−（３−アシルアミノ−２−オキソ−２ｈ−ピリジン−１−イル）−アセチルアミノ］−４−オキソ−ペンタン酸誘導体、およびカスパーゼ阻害剤としてのそれらの使用
KR20100072167A (ko) *	2007-08-03	2010-06-30	사노피-아벤티스	카스파제 이미징 프로브
EP2262783A2 (fr) *	2008-02-21	2010-12-22	Sanofi-Aventis	Sondes d'imagerie à liaison covalente
JP6006908B2 (ja)	2010-11-05	2016-10-12	ブランダイスユニバーシティＢｒａｎｄｅｉｓＵｎｉｖｅｒｓｉｔｙ	Ｉｃｅ阻害化合物およびその使用
US9956260B1 (en)	2011-07-22	2018-05-01	The J. David Gladstone Institutes	Treatment of HIV-1 infection and AIDS
EP2848696A1 (fr)	2013-09-13	2015-03-18	Sanofi-Aventis Deutschland GmbH	Sondes d'imagerie de caspase 1
WO2026082873A1 (fr)	2024-10-17	2026-04-23	Institut National de la Santé et de la Recherche Médicale	Utilisation d'inhibiteurs de caspase-1 pour le traitement de l'érythropoïèse inefficace chez des patients souffrant de drépanocytose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5441960A (en) *	1992-04-16	1995-08-15	Zeneca Limited	1-pyrimidinylacetamide human leukocyte elastate inhibitors
CA2186511C (fr) *	1994-03-31	2009-02-10	Roland E. Dolle	Derives du pyrimidinyle inhibiteurs de l'interleukine

1995
- 1995-03-29 CA CA002186511A patent/CA2186511C/fr not_active Expired - Fee Related
- 1995-03-29 PT PT95915448T patent/PT752987E/pt unknown
- 1995-03-29 CN CN95193258A patent/CN1118458C/zh not_active Expired - Fee Related
- 1995-03-29 NZ NZ283876A patent/NZ283876A/en not_active IP Right Cessation
- 1995-03-29 ES ES95915448T patent/ES2210289T3/es not_active Expired - Lifetime
- 1995-03-29 DK DK95915448T patent/DK0752987T3/da active
- 1995-03-29 AU AU22323/95A patent/AU703451B2/en not_active Ceased
- 1995-03-29 MX MX9604420A patent/MX9604420A/es active IP Right Grant
- 1995-03-29 AT AT95915448T patent/ATE254111T1/de not_active IP Right Cessation
- 1995-03-29 HU HU9602664A patent/HU224731B1/hu not_active IP Right Cessation
- 1995-03-29 DE DE69532113T patent/DE69532113T2/de not_active Expired - Lifetime
- 1995-03-29 EP EP95915448A patent/EP0752987B1/fr not_active Expired - Lifetime
- 1995-03-29 WO PCT/US1995/003909 patent/WO1995026958A1/fr not_active Ceased
- 1995-03-29 CN CNA031452183A patent/CN1504462A/zh active Pending
- 1995-03-29 JP JP52582195A patent/JP3703836B2/ja not_active Expired - Fee Related
- 1995-11-20 US US08/559,870 patent/US5670494A/en not_active Expired - Lifetime
1996
- 1996-09-26 NO NO964058A patent/NO308603B1/no unknown
- 1996-09-27 FI FI963897A patent/FI112943B/fi not_active IP Right Cessation
1997
- 1997-06-17 US US08/877,380 patent/US6162800A/en not_active Expired - Lifetime
2000
- 2000-12-19 US US09/740,623 patent/US6407080B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO1995026958A1 (fr)	1995-10-12
HU224731B1 (en)	2006-01-30
PT752987E (pt)	2004-03-31
JP3703836B2 (ja)	2005-10-05
CA2186511A1 (fr)	1995-10-12
US6162800A (en)	2000-12-19
NO308603B1 (no)	2000-10-02
EP0752987B1 (fr)	2003-11-12
US6407080B2 (en)	2002-06-18
US20010003750A1 (en)	2001-06-14
FI963897A0 (fi)	1996-09-27
US5670494A (en)	1997-09-23
AU2232395A (en)	1995-10-23
EP0752987A4 (fr)	1997-04-09
HK1012623A1 (en)	1999-08-06
FI112943B (fi)	2004-02-13
DE69532113D1 (de)	2003-12-18
NZ283876A (en)	2001-03-30
AU703451B2 (en)	1999-03-25
JPH09511249A (ja)	1997-11-11
EP0752987A1 (fr)	1997-01-15
FI963897L (fi)	1996-09-27
CN1504462A (zh)	2004-06-16
HUT75715A (en)	1997-05-28
MX9604420A (es)	1997-12-31
DE69532113T2 (de)	2004-07-29
CA2186511C (fr)	2009-02-10
CN1149292A (zh)	1997-05-07
NO964058L (no)	1996-09-26
NO964058D0 (no)	1996-09-26
ES2210289T3 (es)	2004-07-01
HU9602664D0 (en)	1996-11-28
ATE254111T1 (de)	2003-11-15
CN1118458C (zh)	2003-08-20

Publication	Publication Date	Title
NO964058L (no)	1996-09-26	Pyrimidinylderivater som interleukininhibitorer
FI942423A0 (fi)	1994-05-25	Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
DE69232929D1 (de)	2003-04-03	Saccharinderivate als proteolytische Enzyminhibitoren
EP1034164A4 (fr)	2001-07-11	Derives d'alanine-beta agissant en tant qu'inhibiteurs de l'adhesion cellulaire
MX9206008A (es)	1993-11-01	Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida.
HUP0101146A2 (hu)	2001-08-28	Foszfolipáz enzim inhibitor hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyászati készítmények
NO20052864L (no)	2005-06-13	Nye hydroksyindoler, deres anvendelse som fosfordiesterase 4 inhibitorer samt fremstilling av forbindelser
DE69413167D1 (de)	1998-10-15	Peptid-Phosphinyloxymethyl-Ketonen als Inhibitoren von Interleukin-1 beta-konvertierenden Enzymen
DK0559743T3 (da)	1995-07-03	Nye hydroxamsyre- og N-hydroxyurinstofderivater og deres anvendelse
NO20002958L (no)	2000-08-11	Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
NO990667L (no)	1999-04-12	Depeptid-benzamidin som kinogenase-inhibitor
YU89202A (sh)	2006-05-25	Faktor viia inhibitorni derivati (tio)uree, njihovo dobijanje i upotreba
DK1049703T3 (da)	2003-06-02	N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2--(4-fluorphenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-L-asparaginsyrealdehyd som en in vivo inhibitor af interleukin-1beta konverterende enzym
NO20025510D0 (no)	2002-11-15	Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer
BR0315662A (pt)	2005-08-30	Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona
FI970469A0 (fi)	1997-02-04	Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
SE9803773D0 (sv)	1998-11-05	Compounds
TR200103550T2 (tr)	2002-05-21	Faktör VIIa inhibitörler.
DK0652874T3 (da)	2004-03-22	2-heterocycliske-5-hydroxy-1,3-pyrimidiner der er nyttige som antiinflammatoriske midler
SE9802650D0 (sv)	1998-07-31	Compounds
NO970498L (no)	1997-02-04	Benzimidazolderivater med dopaminergisk aktivitet